Five Pfizer drugs among first 27 now subject to Medicare inflation rebates, HHS says

The Department of Health and Human Services (HHS) on Wednesday unveiled the first set of 27 Part B prescription drugs, including five from Pfizer, that will be subject to Medicare inflation rebates because their prices rose faster than the rate of inflation.

Seniors receiving the physician-administered drugs beginning in April...

Click to view original post